Prospective real-world experience with risankizumab in difficult-to-treat Crohn’s disease: results from the Dutch Initiative on Crohn and Colitis Registry

Loriane Marina Michèle Verleye, Tessa Straatmijer, Annemarie C de Vries et al.|Inflammatory Bowel Diseases|2026

Cited by 0